Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol/Budesonide vs Foraseq in Persistent Asthma
NCT01001364Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Feb 2010
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of formoterol, budesonide in asthma, sponsored by Eurofarma. Started Feb 2010; status: completed.
02
Drugs
formoterolbudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01001364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001364.